Le Lézard
Classified in: Health
Subject: SLS

Essity publishes Annual and Sustainability Report 2022


Hygiene and health company Essity is today publishing its Annual and Sustainability Report for 2022 on www.essity.com.

STOCKHOLM, March 2, 2023 /PRNewswire/ -- Every day, Essity reaches more than one billion people with its leading hygiene and health solutions with strong brands such as TENA, Tork, Leukoplast, Tempo, Libresse and Libero. In 2022, the company reported record growth and achieved its highest ever net sales. Operating profit before depreciation, amortization and impairment was in line with 2021, despite the strong cost inflation. Through successful innovations and acquisitions, Essity has strengthened and expanded its offerings for the benefit of customers and consumers around the world.

Read Magnus Groth's CEO message and about Essity's strategic priorities, earnings and leading sustainability work in the Annual and Sustainability Report 2022, which is attached to this press release and can be downloaded at www.essity.com

To access the digital short version, please click here

NB: This is information that Essity is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, on March 2, 2023 at 8:00 CET.

Helena Hansen, Media Relations Manager, +46 70 616 96 69

For further information, please contact:
Per Lorentz, Vice President Corporate Communications, +46 733 13 30 55, [email protected]
Johan Karlsson, Vice President Investor Relations, +46 705 11 15 81, [email protected]

The following files are available for download:

https://mb.cision.com/Main/15798/3725860/1884989.pdf

Essity_Annual and Sustainability Report 2022_230302

https://news.cision.com/essity/i/essity-cover-2022-eng,c3150449

Essity cover 2022 ENG

https://mb.cision.com/Public/15798/3725860/a349fc384dfec820.pdf

Essity Press release

 

SOURCE Essity


These press releases may also interest you

at 17:03
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a clinical-stage biotechnology company leveraging its proprietary...

at 16:42
Accelerate Diagnostics, Inc. today announced financial preliminary results for the first quarter ended March 31, 2024. "During the...

at 16:40
Johnson & Johnson will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Jennifer Taubert, Executive Vice President, Worldwide Chairman,...

at 16:37
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that it has set a record date of May 17, 2024 (the "Record Date") for the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary, Inhibrx...

at 16:35
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today provided a business update and financial results for the quarter ended March...

at 16:35
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced new data from a study further confirming the performance of its DecisionDx-UM test as a robust independent predictor of...



News published on and distributed by: